Emerging Role of Focal Therapy in the Management of Prostate Cancer
Daniel Y. Song, MD, discusses focal brachytherapy for treating prostate cancer.
Read More
Johns Hopkins University School of Medicine
Renal Ablation Technologies – Impact on the Treatment of Small Renal Masses
Thomas W. Jarrett, MD, explores the evolving role of renal ablation technologies in managing small renal masses (SRMs), highlighting their increasing importance as an alternative to traditional surgical approaches. In this 20-minute talk, he provides a detailed overview of the various ablation techniques, including radiofrequency ablation (RFA), cryoablation, and microwave ablation, emphasizing their distinct mechanisms of action and clinical applications.
The presentation delves into the outcomes associated with renal ablation, discussing the advantages and disadvantages of the different ablation options. Dr. Jarrett also addresses the limitations and challenges of renal ablation, including the potential for incomplete tumor destruction and the difficulties in monitoring long-term outcomes.
Read More
The Battle of Biopsies: Results of a Multi-institutional Randomized Trial of Transrectal vs Transperitoneal Prostate Biopsy
In this 21-minute conversation, Mohammed E. Allaf, MD, Johns Hopkins University, Baltimore, Maryland, advocates for a reevaluation of current biopsy practices, suggesting that the transperitoneal approach may offer a safer option for patients, particularly in the context of rising concerns over antibiotic resistance.
Read More
iTIND: How I Do It
Amin S. Herati, MD, provides an in-depth analysis of the implantation of the Temporary Implantable Nitinol Device (iTIND) for the treatment of benign prostatic hyperplasia (BPH). His discussion emphasizes the procedural details, benefits, and practical considerations of using iTIND, a minimally invasive therapy designed to relieve urinary symptoms associated with BPH.
Dr. Herati describes the indications for iTIND, highlighting its suitability for patients with moderate to severe BPH who are seeking alternatives to medication or more invasive surgical procedures. The procedural technique is meticulously detailed; Dr. Herati emphasizes the technical aspects critical to the procedure’s success, such as the precise placement of the device and careful monitoring during the implantation and removal processes.
The benefits of iTIND are highlighted, including its minimally invasive nature, rapid symptom relief, and preservation of sexual function. Additionally, the low incidence of complications, such as temporary dysuria and hematuria, is discussed. Challenges and limitations of iTIND are also addressed.
Read More
Prostate Urethral Lift. How I Do It.
Amin S. Herati, MD provides an overview of the prostate urethral lift (PUL) procedure, detailing its application, benefits, and technical execution for the treatment of benign prostatic hyperplasia (BPH). He emphasizes the minimally invasive nature of PUL and its effectiveness in alleviating urinary symptoms while preserving sexual function.
Dr. Herati explains the indications for PUL, stressing the evaluation of prostate size, anatomy, and symptom severity. Ideal candidates typically have lateral lobe enlargement without significant median lobe obstruction.
The procedural technique is outlined with precision, starting with patient preparation and anesthesia. Herati describes the insertion of the cystoscope through the urethra to visualize the prostate and the subsequent deployment of tiny implants to retract the enlarged prostate tissue away from the urethra. Dr. Herati emphasizes the technical aspects critical to the success of the procedure.
The benefits of PUL are highlighted, including its high safety profile, quick recovery, and preservation of erectile and ejaculatory function. Additionally, he discusses complications, which are generally mild and transient. Challenges and limitations of PUL are also addressed.
Read More